Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q1 EPS of ($0.31), $0.02 worse than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.